Psyence Biomedical Equity Warrants Exp 22 Jan 2029 logo

Psyence Biomedical Equity Warrants Exp 22 Jan 2029 Share Price (NASDAQ: PBMWW)

$0.02

Last updated on

Check the interactive Psyence Biomedical Equity Warrants Exp 22 Jan 2029 Stock chart to analyse performance

Psyence Biomedical Equity Warrants Exp 22 Jan 2029 stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$0.02
    Today's High:$0.03

    Day's Volatility :26.47%

  • 52 Weeks Low:$0.00
    52 Weeks High:$0.05

    52 Weeks Volatility :92.52%

Psyence Biomedical Equity Warrants Exp 22 Jan 2029 Stock Returns

PeriodPsyence Biomedical Equity Warrants Exp 22 Jan 2029Index (Russel 2000)
3 Months
42.77%
0.0%
6 Months
17.61%
0.0%
1 Year
-10.18%
0.0%
3 Years
-50.6%
-4.7%

Psyence Biomedical Equity Warrants Exp 22 Jan 2029 Key Stats

Check Psyence Biomedical Equity Warrants Exp 22 Jan 2029 key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$0.02
Open
$0.0248
Today's High
$0.0272
Today's Low
$0.02
Today's Volume
$43.0K
52 Week High
$0.0481
52 Week Low
$0.0036
Revenue TTM
$0.0
EBITDA
$-3.7M
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
0.0%

Stock Returns calculator for Psyence Biomedical Equity Warrants Exp 22 Jan 2029 Stock including INR - Dollar returns

The Psyence Biomedical Equity Warrants Exp 22 Jan 2029 stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Psyence Biomedical Equity Warrants Exp 22 Jan 2029 investment value today

Current value as on today

₹1,05,284

Returns

₹5,284

(+5.28%)

Returns from Psyence Biomedical Equity Warrants Exp 22 Jan 2029 Stock

₹0 (0%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Psyence Biomedical Equity Warrants Exp 22 Jan 2029 Stock

56.0%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Investment in Psyence Biomedical Equity Warrants Exp 22 Jan 2029 Shares from India has grown by 56.0% over the past 30 days, indicating increased transactional activity.

10%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Psyence Biomedical Equity Warrants Exp 22 Jan 2029 Stock from India on INDmoney has increased by 10% in the last 30 days, reflecting an upward trend in search activity.

Analyst Recommendation on Psyence Biomedical Equity Warrants Exp 22 Jan 2029 Stock

Rating
Trend

Psyence Biomedical Equity Warrants Exp 22 Jan 2029 Stock Insights

  • Price Movement

    In the last 7 days, PBMWW stock has moved up by 15.4%
  • PBMWW vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 51.9%

Psyence Biomedical Equity Warrants Exp 22 Jan 2029 Technicals Summary

Sell

Neutral

Buy

Psyence Biomedical Equity Warrants Exp 22 Jan 2029 is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Psyence Biomedical Equity Warrants Exp 22 Jan 2029 Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Psyence Biomedical Equity Warrants Exp 22 Jan 2029 logo
-8.86%
17.61%
-10.18%
-50.6%
-50.6%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
1.77%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
75.87%
111.28%
242.25%

About Psyence Biomedical Equity Warrants Exp 22 Jan 2029

Psyence Biomedical Ltd. engages in the development of botanical psilocybin-based psychedelic medicines. It also evaluates natural psilocybin for the treatment of adjustment disorder in patients with an incurable cancer diagnosis in a palliative care context. The company's lead product candidate is PEX010, which is in Phase IIb clinical study, a capsule containing naturally sourced psilocybin for treatment of anxiety and depression, including associated ailments, such as post-traumatic stress disorder PTSD, stress, grief, and adjustment disorder in the context of palliative care. It has a partnership with iNGENu Pty Ltd to conduct a Phase IIb clinical trial of PEX010 in psilocybin-assisted psychotherapy for the treatment of AjD due to incurable cancer. The company has a strategic collaboration with PsyLabs to produce Ibogaine. The company is based in Toronto, Canada. Psyence Biomedical Ltd. operates as a subsidiary of Psyence Group Inc.
Organization
Psyence Biomedical Equity Warrants Exp 22 Jan 2029
Employees
12
CEO
Dr. Neil Maresky M.D.
Industry
Miscellaneous

Key Management of Psyence Biomedical Equity Warrants Exp 22 Jan 2029

NameTitle
Mr. Jody Aufrichtig
Co-Founder, Executive Chairman & Strategic Business Development Officer
Dr. Neil Maresky M.D.
CEO & Director
Mr. Warwick Ron Corden-Lloyd
Chief Financial Officer
Ms. Taryn Vos
General Counsel

Important FAQs about investing in PBMWW Stock from India :

What is Psyence Biomedical Equity Warrants Exp 22 Jan 2029 share price today?

Psyence Biomedical Equity Warrants Exp 22 Jan 2029 share price today is $0.02 as on at the close of the market. Psyence Biomedical Equity Warrants Exp 22 Jan 2029 share today touched a day high of $0.03 and a low of $0.02.

What is the 52 week high and 52 week low for Psyence Biomedical Equity Warrants Exp 22 Jan 2029 share?

Psyence Biomedical Equity Warrants Exp 22 Jan 2029 share touched a 52 week high of $0.05 and a 52 week low of $0.00. Psyence Biomedical Equity Warrants Exp 22 Jan 2029 stock price today i.e. is closed at $0.02, lower by 58.42% versus the 52 week high.

How to invest in Psyence Biomedical Equity Warrants Exp 22 Jan 2029 Stock (PBMWW) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Psyence Biomedical Equity Warrants Exp 22 Jan 2029 on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Psyence Biomedical Equity Warrants Exp 22 Jan 2029 Shares that will get you 75.0000 shares as per Psyence Biomedical Equity Warrants Exp 22 Jan 2029 share price of $0.02 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Psyence Biomedical Equity Warrants Exp 22 Jan 2029 Stock (PBMWW) from India?

Indian investors can start investing in Psyence Biomedical Equity Warrants Exp 22 Jan 2029 (PBMWW) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Psyence Biomedical Equity Warrants Exp 22 Jan 2029 stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Psyence Biomedical Equity Warrants Exp 22 Jan 2029 share’s latest price of $0.02 as on August 30, 2025 at 1:29 am IST, you will get 500.0000 shares of Psyence Biomedical Equity Warrants Exp 22 Jan 2029. Learn more about fractional shares .

What are the returns that Psyence Biomedical Equity Warrants Exp 22 Jan 2029 has given to Indian investors in the last 5 years?

Psyence Biomedical Equity Warrants Exp 22 Jan 2029 stock has given -50.6% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?